News

  • Fertility tech: How technology in changes women’s health

    Femtech (female technology) is an area of the medical industry gaining prominence for its potential to reduce the gender health gap. As of 2023, this global technology was worth over £22 billion; a figure that’s set to increase at a rate of 16.3 per cent CAGR between 2024 and 2030.  One of the key drivers [...]

  • The rise of femtech: How brands can safeguard customer data

    The global femtech industry is in great shape these days, with steady annual growth having it on course to be valued at $1.186 trillion by 2027.  Though this upward momentum is great news for industry business leaders, it’s important to remember that the rise of femtech comes with higher volumes of private customer data and [...]

  • Lindus Health introduces CRO for clinical trials in women’s health

    Lindus Health has launched its "All-in-One Women's Health CRO" offering of contract research organisation (CRO) and technology solutions bespoke to running clinical trials for women's health products. Women have an increased risk of developing certain diseases like breast cancer, osteoporosis, autoimmune disorders, and more. They may also experience very different treatment responses to medications than [...]

  • Boosting immune cell tolerance may help prevent early pregnancy loss

    Recurrent pregnancy loss can be devastating and exert a major impact on women, their partners, and society more broadly, but currently there are few options for effective therapies. Over several years, there has been mounting evidence that a deficiency in special immune cells called T-regulatory (Treg) cells, which are essential for preparing the uterus for [...]

  • Study identifies how ovarian cancer protects itself, paving way for new drug

    Researchers have discovered a way that ovarian cancer tumours manipulate their environment to resist immunotherapy and identified a drug target that could overcome that resistance. The study used a cutting-edge spatial genomics technology and preclinical animal models, with tumour specimens from ovarian cancer patients further validating the findings. The researchers found that ovarian cancer cells [...]

  • Study links asthma with later age menopause

    Researchers have identified asthma as a risk factor associated with later age menopause. Many studies suggest that an earlier age at menopause is more detrimental to a woman’s health, leading to an increased risk for adverse health conditions such as heart disease, diabetes, osteoporosis, and depression, among others. However, a new study is linking a later age [...]

  • Swiss breast cancer startup announces VA research collaboration

    Swiss startup OncoGenomX, a leader in predictive tumour analytics, has announced a new clinical trial collaboration with researchers of two US Veterans Affairs (VA) Medical Centers. The project will test OncoGenomX’s revolutionary clinical decision support platform PredictionStar™— created with the goal of making personalised precision cancer treatment a reality for all women living with breast [...]

  • Scientists hail ‘new ways’ to improve breast cancer treatment

    Scientists from the University of Sharjah say they have good news for breast cancer patients, particularly those afflicted with the most aggressive types of the malignant tumor known as triple-negative breast cancer. The study, published in the European Journal of Pharmacology, provides “new ways for the treatment of the special type of breast cancer called [...]

  • How AI and software can make a positive difference to maternity outcomes – report

    Women are more likely to receive good care during pregnancy where AI and other clinical software tools are used, a large review of research has found. Researchers conducted a review of over 12,000 papers and 87 articles for different AI and related software tools, investigating the impact of their use in maternity settings. A meta-analysis [...]